Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Biochemistry and Molecular Genetics, University of Louisville School of Medicine, Louisville, Kentucky, USA.
mBio. 2024 Aug 14;15(8):e0190924. doi: 10.1128/mbio.01909-24. Epub 2024 Jul 26.
The presence of the HIV-1 reservoir, a group of immune cells that contain intact, integrated, and replication-competent proviruses, is a major challenge to cure HIV-1. HIV-1 reservoir cells are largely unaffected by the cytopathic effects of viruses, antiviral immune responses, or antiretroviral therapy (ART). The HIV-1 reservoir is seeded early during HIV-1 infection and augmented during active viral replication. CD4+ T cells are the primary target for HIV-1 infection, and recent studies suggest that memory T follicular helper cells within the lymph node, more precisely in the B cell follicle, harbor integrated provirus, which contribute to viral rebound upon ART discontinuation. The B cell follicle, more specifically the germinal center, possesses a unique environment because of its distinct property of being partly immune privileged, potentially allowing HIV-1-infected cells within the lymph nodes to be protected from CD8+ T cells. This modified immune response in the germinal center of the follicle is potentially explained by the exclusion of CD8+ T cells and the presence of T regulatory cells at the junction of the follicle and extrafollicular region. The proviral makeup of HIV-1-infected cells is similar in lymph nodes and blood, suggesting trafficking between these compartments. Little is known about the cell-to-cell interactions, microenvironment of HIV-1-infected cells in the follicle, and trafficking between the lymph node follicle and other body compartments. Applying a spatiotemporal approach that integrates genomics, transcriptomics, and proteomics to investigate the HIV-1 reservoir and its neighboring cells in the lymph node has promising potential for informing HIV-1 cure efforts.
HIV-1 储存库的存在是治愈 HIV-1 的主要挑战,它是一组包含完整、整合和具有复制能力的前病毒的免疫细胞。HIV-1 储存库细胞在很大程度上不受病毒的细胞病变效应、抗病毒免疫反应或抗逆转录病毒治疗 (ART) 的影响。HIV-1 储存库在 HIV-1 感染早期播种,并在病毒复制活跃时增加。CD4+T 细胞是 HIV-1 感染的主要靶细胞,最近的研究表明,淋巴结内的记忆滤泡辅助 T 细胞(更确切地说是在 B 细胞滤泡内)携带整合的前病毒,这有助于在停止 ART 后病毒反弹。B 细胞滤泡,更确切地说是生发中心,由于其部分免疫特权的独特特性,拥有独特的环境,这可能使淋巴结内感染 HIV-1 的细胞免受 CD8+T 细胞的攻击。生发中心滤泡中的这种改变的免疫反应可能是由于 CD8+T 细胞的排除和滤泡和滤泡外区域交界处的 T 调节细胞的存在。淋巴结和血液中 HIV-1 感染细胞的前病毒组成相似,提示这些隔室之间存在转移。关于生发中心滤泡中 HIV-1 感染细胞的细胞间相互作用、微环境和淋巴结滤泡与其他身体隔室之间的转移,人们知之甚少。应用整合基因组学、转录组学和蛋白质组学的时空方法来研究 HIV-1 储存库及其在淋巴结中的邻近细胞,对于为 HIV-1 治愈努力提供信息具有很大的潜力。